日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Produce Prescription Subsidy for Patients With Diabetes: A Pragmatic Randomized Clinical Trial

为糖尿病患者提供处方药补贴:一项务实的随机临床试验

Drake, Connor; Buckman, Cierra; Brucker, Amanda; McPeek Hinz, Eugenia; Pignone, Michael; Shaikha, Huda; Rader, Abigail; Granados, Isa; Goldstein, Benjamin A; Chamorro, Ceci; Hoeffler, Sam; Wirth, Cathy; Spratt, Susan E

PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registry

使用奥拉帕尼和他拉唑帕尼抑制PARP活性治疗HER2阴性晚期乳腺癌——来自前瞻性PRAEGNANT注册研究的结果

Hörner, Manuel; Hartkopf, Andreas; John, Nelson; Ziegler, Philipp; Häberle, Lothar; Uhrig, Sabrina; Goossens, Chloë; Amann, Niklas; Cieslik, Jan-Philipp; Tretschock, Lara M; Dannehl, Dominik; Deutsch, Thomas M; Dimpfl, Moritz; Ehlert, Max; Eichstädt, Kathleen; Englisch, Alexander; Köpke, Melitta B; Krückel, Annika; Link, Theresa; Müller, Annika; Reinhardt, Kristin; Roth, Jonas; Schäffler, Henning; Sych, Lea; Tauber, Nikolas; Tegeler, Christian M; Wichmann, Catharina; Banys-Paluchowski, Maggie; Princk, Henriette; Rody, Achim; Brucker, Sara Y; Ditsch, Nina; Ettl, Johannes; Fehm, Tanja; Hack, Carolin C; Hadji, Peyman; Hein, Alexander; Janni, Wolfgang W; Kolberg, Hans-Christian; Lüftner, Diana; Lux, Michael P; Müller, Volkmar; Taran, Florin-Andrei; Tesch, Hans; Wallwiener, Diethelm; Marmé, Frederik; Seitz, Stephan; Belleville, Erik; Michel, Laura L; Wallwiener, Markus; Fasching, Peter A; Schneeweiss, Andreas; Maurer, Christian

Tumor-associated epilepsy and high expression of xCT shape the proteome of IDH-wildtype glioblastoma.

肿瘤相关性癫痫和 xCT 的高表达塑造了 IDH 野生型胶质母细胞瘤的蛋白质组。

Divé Iris, Schäfer Jasmin A, Weber Katharina J, Çakır Ali Yavuz, Verheyden Nikita A, Lorenz Nadja I, Chong Seon-Ah, Zeiner Pia S, Franiczek Carmen, Sauer Benedikt, Adrian-Allgood Martin, Urban Hans, Luger Anna-Luisa, Wenger Katharina J, Strzelczyk Adam, Rosenow Felix, Streffer Johannes, Prinz Vincent, Brucker Daniel P, Dedeurwaerdere Stefanie, André Véronique M, Steinbach Joachim P, Buettner Florian, Münch Christian, Ronellenfitsch Michael W

Recovery After Transcervical Fibroid Ablation Versus Minimally Invasive Myomectomy for Symptomatic Uterine Fibroids: A Randomised Controlled Trial

经宫颈子宫肌瘤消融术与微创子宫肌瘤切除术治疗症状性子宫肌瘤的术后恢复情况:一项随机对照试验

Neis, Felix; Kraemer, Bernhard; Bauer, Armin; Dijkstra, Tjeerd; Matovina, Sabine; Rohner, Annika; Brucker, Sara Y

Scaling genomic reanalysis to unlock diagnoses and transform rare disease care

扩大基因组再分析规模,以突破诊断难题,变革罕见病治疗。

Rockowitz, Shira; Shao, Wanqing; French, Courtney; Truong, Tina K; Hagen, Jacob; McGonigle, Rylee; Geltzeiler, Alexa; Sheidley, Beth; Smith, Lacey; D'Gama, Alissa M; Irons, Mira; Chou, Janet; Stoler, Joan; Kritzer, Amy; Rodan, Lance; Shimamura, Akiko; Bodamer, Olaf; Sacharow, Stephanie; Soul, Janet S; Srivastava, Siddharth; Kennedy, Amy Roberts; Abu-El-Haija, Aya; Lai, Abbe; Olson, Heather; Juusola, Jane; Ryan, Erin; Friedman, Bethany; Singh, Anupama; Li, Cliff; Mallik, Rittika; Strickland, Gwendolyn; Prinzing, Gillian; Mo, Alisa; O'Donnell-Luria, Anne; Bolton, Jeff; Boone, Philip M; Brucker, William; Duyzend, Michael; Mahida, Sonal; Miller, David T; Omorodion, Jacklyn; Petit, Jeanette; Picker, Jonathan; Poduri, Annapurna; Carlston, Colleen; Wojcik, Monica H; Sliz, Piotr; Chung, Wendy K

Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial

在德国PRAEGNANT试验中,Alpelisib和Fulvestrant被用于治疗PIK3CA突变、激素受体阳性、HER2阴性的晚期乳腺癌。

Hörner, Manuel; Tretschock, Lara M; John, Nelson; Ziegler, Philipp; Häberle, Lothar; Uhrig, Sabrina; Goossens, Chloë; Amann, Niklas; Cieslik, Jan-Philipp; Dannehl, Dominik; Deutsch, Thomas M; Dimpfl, Moritz; Ehlert, Max; Eichstädt, Kathleen; Englisch, Alexander; Köpke, Melitta B; Krückel, Annika; Link, Theresa; Müller, Annika; Reinhardt, Kristin; Roth, Jonas; Schäffler, Henning; Sych, Lea; Tegeler, Christian M; Wichmann, Catharina; Banys-Paluchowski, Maggie; Princk, Henriette; Rody, Achim; Brucker, Sara Y; Ditsch, Nina; Ettl, Johannes; Fehm, Tanja; Hack, Carolin C; Hadji, Peyman; Hein, Alexander; Janni, Wolfgang W; Kolberg, Hans-Christian; Lüftner, Diana; Lux, Michael P; Müller, Volkmar; Schneeweiss, Andreas; Taran, Florin-Andrei; Tesch, Hans; Wallwiener, Diethelm; Marmé, Frederik; Seitz, Stephan; Belleville, Erik; Hartkopf, Andreas; Michel, Laura L; Wallwiener, Markus; Fasching, Peter A; Tauber, Nikolas

The adverse prognostic impact of reduced chemotherapy dose intensity appears attenuated in early breast cancer patients with treatment-relevant neutropenia: a retrospective cohort study

一项回顾性队列研究表明,降低化疗剂量强度对早期乳腺癌伴治疗相关性中性粒细胞减少症患者的不良预后影响似乎有所减弱。

Eissler, K; Engler, T; Dannehl, D; Schönfisch, B; Englisch, J; Hartkopf, A D; Brucker, S Y; Grischke, E M; Volmer, L L; Englisch, Alexander

Electrochemotherapy as a symptom-oriented palliative treatment option: an exploratory single-center study in 15 patients with locally advanced or locoregionally recurrent vulvar carcinoma

电化学疗法作为一种以症状为导向的姑息治疗选择:一项针对15例局部晚期或局部复发性外阴癌患者的探索性单中心研究

Grischke, Eva-Maria; Neis, Felix; Oberlechner, Ernst; Henes, Melanie; Weiß, Martin; Brucker, Sara Y

Impact of chemotherapy dose capping on treatment intensity and survival in early breast cancer patients with high body surface area

化疗剂量上限对体表面积较大的早期乳腺癌患者的治疗强度和生存率的影响

Englisch, A; Eissler, K; Dannehl, D; Englisch, J; Hartkopf, A D; Brucker, S Y; Grischke, E M; Volmer, L L; Engler, T

Long-term results of apical prolapse correction by unilateral pectineal suspension: A clinical trial

单侧耻骨悬吊术矫正顶端脱垂的长期疗效:一项临床试验

Brucker, Cosima Veronika Maria; Bolovis, Dimitrios Ilias; Schreibmayer, Michael; Hitzl, Wolfgang